Read the following press release delivered by PubMed on July 19, 2009. Not only does this mark a significant turn-around from the “Head in the Sand” position CDC has meticulously maintained up until now, but for the release to come through PubMed, the website that most conventio…
Read the following press release delivered by PubMed on July 19, 2009.
Not only does this mark a significant turn-around from the “Head in the Sand” position
CDC has meticulously maintained up until now, but for the release to come through PubMed, the website that most conventional physicians turn to for their research, indicates a softening of the hardline previously maintained by PubMed regarding Lyme disease.
Lyme Disease Receives CDC Budgetary Increase
On July 17, 2009 the HHS Appropriations Committee reported an increase of $3.66 million for Lyme disease, from $5.27 million to $8.93 million, for the Centers for Disease Control &
Prevention (CDC), the only increase for diseases in the National Center for Zoonotic and Vector-Borne, and Enteric Diseases.
Wall Township, NJ (PRWEB) July 22, 2009 — The Lyme Disease Association (LDA), Time for Lyme (TFL), and the California Lyme Disease Association (CALDA) are pleased to announce that on July 17, 2009, the Fiscal 2010 Labor, HHS Appropriations Committee reported out language on Lyme disease which was written and introduced by Congressman Christopher Smith (R-NJ). U.S. House
Appropriations Committee Members Frank Wolf (R-VA), and Nita Lowey (D-NY) were instrumental in its inclusion. The next step is consideration by the full US House of Representatives.
The language includes an increase of $3.66 million for Lyme disease, from $5.27 million to $8.93 million, for the Centers for Disease Control & Prevention (CDC), the only increase for diseases in the National Center for Zoonotic and Vector-Borne, and Enteric Diseases. CDC’s budget for Lyme has been dropping over several
The language directs the Secretary of the U.S. Department of Health and Human Services to review and coordinate her department’s Lyme activities and to report back on that review by September 2010. It also encourages CDC to improve diagnostics and the National Institutes of Health (NIH) to provide a conference on the full spectrum of Lyme disease, allowing for patient input.
COMMENTS FROM ADVOCATES
The three Groups thank Congressman Chris Smith, Congressman Frank Wolf, and
Congresswoman Nita Lowey for their bi-partisan support in this effort to provide more answers on Lyme and tick-borne diseases. They also express deep gratitude to Lyme patients everywhere who responded to alerts and contacted their Congressional Members on Appropriations.
Pat Smith, President, national LDA, who has been spearheading this effort nationally, states “We are extremely pleased that House Appropriators have recognized the need to focus much more attention and funding on all aspects of Lyme
disease, especially chronic. As Lyme case numbers increase, with over 270,000 new cases in 2007 alone, tens of thousands of patients are becoming disabled annually from chronic disease, due to lack of early diagnosis or lack of appropriate treatment, thus the need for a definitive test.”
“Lyme disease affects children more than any other age group,” add Diane Blanchard, and Deb Siciliano, co-presidents of TFL, and they may be out of school for months and years. Thus, there is an urgent need for
the Committee language for dissemination of accurate information to both the public and to physicians, so we can prevent children from acquiring Lyme disease and educate their physicians on the disease if they do get it.”
The need for a broad spectrum of scientific viewpoints has been pushed for many years by patients. According to Attorney Lorraine Johnson, Executive Director of CALDA, “Patients have been excluded from the process too long and their participation in this conference is critical
to ensure that patient interests take precedence over commercial industry interests. We need to stop mischaracterizing the opinions of a few as science and consider the full spectrum of the emerging science in Lyme to make progress. “
LANGUAGE IN APPROPRIATIONS
“Tick-borne Diseases. – The Committee directs the Secretary to review the coordination of efforts across HHS operating divisions with respect to tick-borne diseases to ensure that: a broad spectrum of scientific viewpoints is
represented in public health policy decisions, accurate information is disseminated to the public and physicians, and actions are taken by the Department that will foster significant progress in the development and adoption of improved diagnostics for Lyme disease. The Department shall submit a report to the Committees on Appropriations of the House of Representatives and Senate with the findings from this review not later than September 30, 2010.
“Lyme Disease. – The Committee encourages CDC to
expand its activities related to developing sensitive and more accurate diagnostic tools and tests for Lyme disease, including the evaluation of emerging diagnostic methods and improving utilization of diagnostic testing to account for the multiple clinical manifestations of acute and chronic Lyme disease; to expand its epidemiological research activities on tick-borne diseases to include an objective to determine the long-term course of illness for Lyme disease; to improve surveillance and reporting of Lyme
and other tick-borne diseases in order to produce more accurate data on their prevalence; to evaluate the feasibility of developing a national reporting system on Lyme disease, including laboratory reporting; and to expand prevention of Lyme and tick-borne diseases through increased community-based public education and creating a physician education program that includes the full spectrum of scientific research on the diseases.
“Lyme Diseases. – The Committee encourages NIH to intensify research on
tick-borne diseases including research that will increase understanding of the full range of Lyme disease processes and the physiology of Borrelia burgdorferi, including the mechanisms of persistent infection. Recognizing NIH’s collaborative role with CDC and other agencies in the development of diagnostics, the Committee encourages NIH to support research that may lead to the development of more sensitive and accurate diagnostic tests for Lyme disease capable of distinguishing between active and past
infections. The Committee encourages the Director, in collaboration with the Director of NIAD, to sponsor a scientific conference on Lyme and other tick-borne diseases. The Committee believes that the conference should represent the broad spectrum of scientific views on Lyme disease and should provide a forum for public participation and input from individuals with Lyme disease.”
The all volunteer national Lyme Disease Association